Sign in

CIK 0001783183

  • Non-accelerated filer
  • Smaller reporting company

Phathom Pharmaceuticals, Inc.

Sign in to watch
Ticker
PHAT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
824151574
Phone
+1 877-742-8466
Business address
100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-12-02 Nabulsi Azmi Chief Operating Officer Sale −4,307 $45.05 $194K 841,195
2020-12-02 Nabulsi Azmi Chief Operating Officer Sale −2,995 $45.57 $136K 838,200
2020-12-01 Nabulsi Azmi Chief Operating Officer Sale −5,370 $43.99 $236K 847,330
2020-12-01 Nabulsi Azmi Chief Operating Officer Sale −1,828 $44.83 $82K 845,502
2020-11-02 Nabulsi Azmi Chief Operating Officer Sale −14,500 $36.83 $534K 852,700
2020-07-01 Nabulsi Azmi Chief Operating Officer Grant or award · Stock Option (Right to Buy) +70,000 70,000
2020-06-25 Nabulsi Azmi Chief Operating Officer Gift −867,200 0
2020-06-25 Nabulsi Azmi Chief Operating Officer Gift +867,200 867,200
2020-01-05 Nabulsi Azmi Chief Operating Officer Sale −1,854 $33.77 $63K 823,700
2020-01-04 Nabulsi Azmi Chief Operating Officer Sale −4,932 $33.02 $163K 833,268
2020-01-04 Nabulsi Azmi Chief Operating Officer Sale −7,614 $33.93 $258K 825,654
2020-01-04 Nabulsi Azmi Chief Operating Officer Sale −100 $34.57 $3K 825,554

Page 3 of 3 · 52 trades